Alaunos Therapeutics, Inc.股价飙升11.68% 市值涨1.59万美元

市场透视10-04

北京时间2024年10月04日22时17分，Alaunos Therapeutics, Inc.（TCRT.us）股票出现波动，股价急速拉升11.68%。截至发稿，该股报3.06美元/股，成交量1965股，换手率0.12%，振幅0.73%。最近的财报数据显示，该股实现营业收入4000.00美元，净利润-1.13百万美元，每股收益-0.71美元，毛利3000.00美元，市盈率-0.01倍。机构评级...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2472795072?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-10-04 22:17","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2472795072","market":"us","top_or_hot":-1,"title":"Alaunos Therapeutics, Inc.股价飙升11.68% 市值涨1.59万美元","media":"市场透视","content":"<div>\n<p>北京时间2024年10月04日22时17分，Alaunos Therapeutics, Inc.（TCRT.us）股票出现波动，股价急速拉升11.68%。截至发稿，该股报3.06美元/股，成交量1965股，换手率0.12%，振幅0.73%。最近的财报数据显示，该股实现营业收入4000.00美元，净利润-1.13百万美元，每股收益-0.71美元，毛利3000.00美元，市盈率-0.01倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004221738ab67bdfe&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alaunos Therapeutics, Inc.股价飙升11.68% 市值涨1.59万美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlaunos Therapeutics, Inc.股价飙升11.68% 市值涨1.59万美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-04 22:17 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004221738ab67bdfe&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年10月04日22时17分，Alaunos Therapeutics, Inc.（TCRT.us）股票出现波动，股价急速拉升11.68%。截至发稿，该股报3.06美元/股，成交量1965股，换手率0.12%，振幅0.73%。最近的财报数据显示，该股实现营业收入4000.00美元，净利润-1.13百万美元，每股收益-0.71美元，毛利3000.00美元，市盈率-0.01倍。机构评级...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004221738ab67bdfe&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004221738ab67bdfe&s=b","article_id":"2472795072","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004221738ab67bdfe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2472795072","pubTimestamp":1728051458,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年10月04日22时17分，Alaunos Therapeutics, Inc.股票出现波动，股价急速拉升11.68%。Alaunos Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Aditxt, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Aditxt, Inc.、Theriva Biologics, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为13661.32%、45.63%、32.88%，振幅较大的相关个股有Aditxt, Inc.、Geovax Labs Inc C/Wts 29/09/2025、Sagimet Biosciences Inc. - Series A，振幅分别为47.42%、40.36%、24.51%。Alaunos Therapeutics, Inc.公司简介：Alaunos Therapeutics Inc 是一家临床阶段的细胞免疫肿瘤公司，致力于通过过继性TCR-T 细胞疗法治疗实体瘤。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","TCRT":"Alaunos Therapeutics","LENZ":"Therapeutics"},"translate_title":"Alaunos Therapeutics, Inc. Stock Soars 11.68%, Market Cap Ups $15,900","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1,"TCRT":1},"content_text":"北京时间2024年10月04日22时17分，Alaunos Therapeutics, Inc.（TCRT.us）股票出现波动，股价急速拉升11.68%。截至发稿，该股报3.06美元/股，成交量1965股，换手率0.12%，振幅0.73%。最近的财报数据显示，该股实现营业收入4000.00美元，净利润-1.13百万美元，每股收益-0.71美元，毛利3000.00美元，市盈率-0.01倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Alaunos Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。其相关个股中，Tc Biopharm (Holdings) Plc C/Wts 10/02/2028 (To Pur Ads)、Aditxt, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 (To Pur Com)涨幅较大，Aditxt, Inc.、Theriva Biologics, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为13661.32%、45.63%、32.88%，振幅较大的相关个股有Aditxt, Inc.、Geovax Labs Inc C/Wts 29/09/2025(To Pur Com)、Sagimet Biosciences Inc. - Series A，振幅分别为47.42%、40.36%、24.51%。Alaunos Therapeutics, Inc.公司简介：Alaunos Therapeutics Inc 是一家临床阶段的细胞免疫肿瘤公司，致力于通过过继性TCR-T 细胞疗法治疗实体瘤。 该公司通过设计针对基因组突变产生的新抗原的细胞疗法来打击癌症的核心。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2472795072"}